NEW YORK (GenomeWeb News) – The US Centers for Disease Control and Prevention plans to spend $2.7 million to support projects conducted by state and local governments to adopt evidence-based recommendations for genomic tests and other interventions for breast cancer.
The three-year program will provide $900,000 per year for three awards that will range between $200,000 and $300,000 each to support the projects, which are not to involve research activities.
The aim of the program is to adopt interventions in health practice that will help maximize the health benefits and minimize the potential harms of genomic tests for young women who are at high risk of developing breast cancer, the most commonly diagnosed cancer for women in the US.
To do that, these grants will fund state health departments to enhance their capabilities to promote the application of breast cancer genomics best practices through education, surveillance, and policy.
Applicants for the funding will propose to develop or enhance activities related to breast cancer genomics, such as increasing BRCA1 and BRCA2 counseling and testing; increasing coverage of appropriate BRCA1/2-related interventions; and developing educational programs to increase knowledge about breast cancer-related family history, risk assessment, and BRCA1/2 counseling for the public and healthcare providers.
CDC started the program because the Affordable Care Act of 2009 called for the agency to address breast cancer in young women and because it sees a need for enhancements in public health programs that use genomics.
According to the CDC, programs in policy and education are needed to help translate evidence-based genomic applications into clinical practice, and to increase the understanding of healthcare professionals and the public of the harms and benefits of breast cancer genomics.
Surveillance also is needed for breast cancer genomic applications and their outcomes, CDC said in its funding announcement.